Apollomics (APLM) Cash & Current Investments (2020 - 2025)
Apollomics (APLM) posted quarterly Cash & Current Investments of $3.3 million for Q4 2025, down 92.83% quarter-over-quarter from $45.7 million in Q2 2023.
Apollomics (APLM) Cash & Current Investments (2020 - 2025) Analysis & Trends
Apollomics (APLM) has reported Cash & Current Investments for 5 consecutive years, with $3.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash & Current Investments changed N/A year-over-year to $3.3 million; the TTM figure through Dec 2025 stood at $3.3 million (changed N/A YoY), while the FY2025 annual figure was $3.3 million, changed N/A from the prior year.
- Cash & Current Investments retreated to $3.3 million in Q4 2025 per APLM's latest filing, from $45.7 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $51.7 million in Q4 2022 and bottomed at $3.3 million in Q4 2025.
- Historically, Cash & Current Investments has averaged $36.3 million across 4 years, with a median of $45.7 million in 2023.
- Annual changes were most pronounced in 2021 — Cash & Current Investments sank 76.86% — and 2022, when it soared 71.16%.
- Apollomics' Cash & Current Investments stood at $30.2 million in 2021, then jumped by 71.16% to $51.7 million in 2022, then decreased by 11.68% to $45.7 million in 2023, then sank by 92.83% to $3.3 million in 2025.
- Business Quant data shows APLM's Cash & Current Investments at $3.3 million in Q4 2025, $45.7 million in Q2 2023, and $51.7 million in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 836.99 Mn |
| 10 | Apollomics | 35.18 Mn | 31.90 Mn | - | 3.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.28 Mn |
| Jun 30, 2023 | 45.70 Mn |
| Dec 31, 2022 | 51.74 Mn |
| Jun 30, 2022 | 50.70 Mn |
| Dec 31, 2021 | 30.23 Mn |
| Dec 31, 2020 | 130.65 Mn |